Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/31/2025

Proctocort (Hydrocortisone Acetate) Suppository Treatment Duration and Management

Indication and Position in Therapy

  • Corticosteroid suppositories are recommended as second‑line therapy for mild‑to‑moderate proctitis, to be used only after failure or intolerance to first‑line 5‑ASA suppositories (1 g daily), which have superior efficacy and safety. 3
  • The British Society of Gastroenterology advises adding a prednisolone 5 mg suppository in the morning while continuing 5‑ASA at bedtime for patients with an incomplete response to 5‑ASA alone. 6

Efficacy Compared with 5‑ASA

  • Rectal 5‑ASA is more effective than rectal corticosteroids for inducing remission (relative risk 0.74; 95 % CI 0.61–0.90). 1

Treatment Duration and Response Assessment

  • Induction courses of rectal corticosteroid suppositories should last 2–4 weeks to achieve remission in mild‑to‑moderate proctitis. 1
  • Clinical response should be evaluated at 4–8 weeks; lack of remission warrants therapy modification. 4

Safety and Maintenance Limitations

  • Long‑term maintenance with corticosteroid suppositories is not advised because prolonged use can lead to systemic side effects; no trials support maintenance beyond the acute induction phase. 2
  • Corticosteroid suppositories must not be continued beyond 4 weeks without reassessment, as this increases systemic risk without proven benefit. 1

Management of Incomplete or Refractory Response

  • If remission is not achieved after 2–4 weeks, escalation to oral prednisolone 40 mg daily (tapered over 6–8 weeks) or to immunomodulatory/biologic therapy is recommended. 6
  • Prior to escalation, verify patient adherence and proper insertion technique. 6
  • Exclude alternative diagnoses (infectious colitis, proximal constipation, Crohn’s disease, IBS, solitary rectal ulcer, chemical colitis, rectal prolapse) when response is inadequate. 5
  • Consider sigmoidoscopy or colonoscopy to rule out more extensive disease before moving to systemic therapy. 6
  • Escalate to systemic therapy rather than extending topical corticosteroid use in refractory cases. 6

Practical Pitfalls to Avoid

  • Do not use corticosteroid suppositories as first‑line therapy before a trial of 5‑ASA. 5
  • Do not employ corticosteroid suppositories for maintenance; once remission is achieved, switch to 5‑ASA suppositories for ongoing control. 6